Open access peer-reviewed chapter

Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders

By Masahiko Suzuki

Submitted: October 21st 2010Reviewed: June 21st 2011Published: February 8th 2012

DOI: 10.5772/17517

Downloaded: 1439

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Masahiko Suzuki (February 8th 2012). Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders, Mechanisms in Parkinson's Disease - Models and Treatments, Juliana Dushanova, IntechOpen, DOI: 10.5772/17517. Available from:

chapter statistics

1439total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Update in Parkinson’s Disease

By Fátima Carrillo and Pablo Mir

Related Book

First chapter

Early Marker for the Diagnosis of Parkinson's Disease

By Silvia Marino, Pietro Lanzafame, Silvia Guerrera, Rosella Ciurleo and Placido Bramanti

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us